TotalMarketCap

TriSalus Life Sciences

TLSINasdaq United StatesHealth CareMedical Specialities

Market cap

$217.358 M

$3.53 -9.25%

Close of 6 Nov 2026

As of 6 Nov 2026, TriSalus Life Sciences (TLSI) has a market capitalization of $217.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$45.2M

#2746 by revenue

Earnings

-$39.2M

Loss-making

Shares outstanding

61,574,600

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

TriSalus Life Sciences lists more than one class of stock. Company figures above cover all classes combined.

TLSIW

Medical Specialities, ranked by market cap

All 44 →
  1. #31YD BioYDES$511.4M
  2. #32Fulgent GeneticsFLGT$511.0M
  3. #33TriSalus Life SciencesTLSI$217.4M
  4. #34BiodesixBDSX$211.0M
  5. #35ExagenXGN$181.4M

What if TriSalus Life Sciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$458,579.90

Per share 129,909× higher

Bitcoin $1.53T

$24,812.96

Per share 7,029× higher

Apple $5.02T

$81,458.63

Per share 23,076× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for TriSalus Life Sciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.